
Endocrinology & Metabolism
Orlistat Kidney-Injury Warning Now Covers OTC Alli
The FDA has approved revised labeling for OTC orlistat (alli) warning of rare acute kidney injury, bringing kidney-risk messaging into line across US orlistat products.
Rayan Salih · August 27, 2026 · 6 min
